Awards podcast: DCC on transactions, litigation and IP in Asia-Pacific

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Awards podcast: DCC on transactions, litigation and IP in Asia-Pacific

L to R: Chris Jordan, David Webber, Michael Wolnizer

In the latest in MIP’s awards series, Joanna Yang chats to Australian firm Davies Collison Cave about its work in pharma and its outlook on the pandemic

Davies Collison Cave won two Managing IP Asia-Pacific awards in 2020: patent prosecution firm of the year for Australia, and boutique firm of the year for the whole region. With offices in Singapore and New Zealand as well as in Australia, the firm works with clients across Asia-Pacific.

In this latest awards podcast, Joanna Yang, editor of Benchmark Litigation Asia-Pacific, talked to three DCC lawyers – group managing principal Michael Wolnizer, managing principal of patents David Webber, and Chris Jordan, managing principal of DCC’s associated law firm Davies Collison Cave Law – in an engaging exploration of the firm’s operations across the Asia-Pacific region.

Click below to listen to the podcast.


 

more from across site and SHARED ros bottom lb

More from across our site

The Texas-based IP litigation hires take King & Spalding’s partner appointments from pre-merger Winston & Strawn up to 12 this year
Sunny Su explains how her team overcame challenges with orchard evidence collection to secure a favourable plant variety decision from China’s top court
Flexible working firm continues trajectory from 2025 with appointment of Matthew Grant and Letao Qin
Anousha Davies, associate and trademark attorney at Birketts, unpicks how the university’s reputation enabled it to see off a proposed trademark for ‘Cambridge Rowing’
IP lawyers, who say they are encouraging clients to build up ‘tariff resilience’, should treat the risks posed by recent orders as a core consideration in cross-border licensing
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Simon Wright explains why the UK should embrace the possibility of rejoining the UPC, and reveals how CIPA is reacting to this month’s historic Emotional Perception AI case at the UK Supreme Court
Gift this article